Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1361-1370 of 3395 for cancer

Edit search filters
  1. Stereotactic Body Radiation Therapy with Immunotherapy for the Treatment of Mesothelioma

    Rochester, MN

  2. A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma

    Jacksonville, FL, Rochester, MN

  3. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma

    Rochester, MN

  4. Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI

    Scottsdale/Phoenix, AZ

  5. Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

    Rochester, MN

  6. A Study to Evaluate the Safety and Effectiveness of Hypofractionation Proton Beam Therapy in Patients with Clinically Localized, Intermediate, or High Risk Prostate Cancer

    Rochester, MN, Scottsdale/Phoenix, AZ

  7. A Phase 1/2 Study to Evaluate MEDI4736

    Jacksonville, FL

  8. Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

    Scottsdale/Phoenix, AZ

  9. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant

    Scottsdale/Phoenix, AZ

  10. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer